Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
616.29
329.00
233.66
2.79
6.69
0.15
0.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
616.29
329.00
233.66
2.79
6.69
0.15
0.15
Raw Material Cost
100.71
38.77
14.55
0.78
0.79
0.37
0.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
26.73
24.03
12.62
10.19
5.64
6.33
4.09
Selling and Distribution Expenses
232.03
154.02
122.28
69.49
128.09
107.48
15.95
Other Expenses
13.35
7.03
6.36
11.52
21.69
15.96
15.01
Total Expenditure (Excl Depreciation)
492.96
287.07
213.03
195.62
351.46
273.75
170.41
Operating Profit (PBDIT) excl Other Income
123.3
41.900000000000006
20.6
-192.8
-344.79999999999995
-273.6
-170.3
Other Income
11.09
8.45
4.03
3.50
0.71
0.31
0.67
Operating Profit (PBDIT)
136.41
50.66
25.08
-188.82
-343.57
-272.91
-169.30
Interest
26.73
24.03
12.62
10.19
5.64
6.33
4.09
Exceptional Items
-0.30
-0.75
1.02
1.19
1.60
0.23
0.80
Gross Profit (PBDT)
515.57
290.24
219.11
2.00
5.90
-0.22
-0.13
Depreciation
1.99
0.28
0.42
0.52
0.49
0.37
0.28
Profit Before Tax
107.39
25.59
13.06
-198.34
-348.10
-279.38
-172.87
Tax
-339.79
2.21
0.39
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
447.18
23.38
12.67
-198.34
-348.10
-279.38
-172.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
447.18
23.38
12.67
-198.34
-348.10
-279.38
-172.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
447.18
23.38
12.67
-198.34
-348.10
-279.38
-172.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
648.02
222.36
160.50
58.59
237.15
519.35
38.62
Earnings per share (EPS)
2.77
0.15
0.09
-1.46
-2.63
-2.42
-1.96
Diluted Earnings per share
2.77
0.15
0.09
-1.46
-2.63
-2.42
-1.96
Operating Profit Margin (Excl OI)
20.01%
12.74%
8.83%
-6924.2%
-5154.28%
-179996.05%
-112009.87%
Gross Profit Margin
17.75%
7.86%
5.77%
-7103.05%
-5196.7%
-183557.24%
-113545.39%
PAT Margin
72.56%
7.11%
5.42%
-7121.54%
-5204.08%
-183803.29%
-113730.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 87.33% vs 40.78% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 1,811.11% vs 84.25% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 196.92% vs 100.00% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 11.25% vs 90.48% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of TG Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
616.29
588.99
27.30
4.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
616.29
588.99
27.30
4.64%
Raw Material Cost
100.71
124.75
-24.04
-19.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
26.73
0.00
26.73
Selling and Distribution Expenses
232.03
193.75
38.28
19.76%
Other Expenses
13.35
1.27
12.08
951.18%
Total Expenditure (Excl Depreciation)
492.96
331.21
161.75
48.84%
Operating Profit (PBDIT) excl Other Income
123.32
257.78
-134.46
-52.16%
Other Income
11.09
24.77
-13.68
-55.23%
Operating Profit (PBDIT)
136.41
320.71
-184.30
-57.47%
Interest
26.73
0.00
26.73
Exceptional Items
-0.30
0.97
-1.27
-130.93%
Gross Profit (PBDT)
515.57
464.24
51.33
11.06%
Depreciation
1.99
38.17
-36.18
-94.79%
Profit Before Tax
107.39
283.51
-176.12
-62.12%
Tax
-339.79
69.19
-408.98
-591.10%
Provisions and contingencies
0
0
0.00
Profit After Tax
447.18
214.33
232.85
108.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
447.18
214.33
232.85
108.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
447.18
214.33
232.85
108.64%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
648.02
954.27
-306.25
-32.09%
Earnings per share (EPS)
2.77
1.68
1.09
64.88%
Diluted Earnings per share
2.77
1.68
1.09
64.88%
Operating Profit Margin (Excl OI)
20.01%
43.77%
0.00
-23.76%
Gross Profit Margin
17.75%
54.62%
0.00
-36.87%
PAT Margin
72.56%
36.39%
0.00
36.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 61.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 87.33% vs 40.78% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 44.72 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1,811.11% vs 84.25% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.53 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 196.92% vs 100.00% in Dec 2024
Annual - Interest
Interest 2.67 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 11.25% vs 90.48% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.01%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
